355 related articles for article (PubMed ID: 11334491)
1. Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis.
Steere AC; Gross D; Meyer AL; Huber BT
J Autoimmun; 2001 May; 16(3):263-8. PubMed ID: 11334491
[TBL] [Abstract][Full Text] [Related]
2. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi.
Chen J; Field JA; Glickstein L; Molloy PJ; Huber BT; Steere AC
Arthritis Rheum; 1999 Sep; 42(9):1813-22. PubMed ID: 10513794
[TBL] [Abstract][Full Text] [Related]
3. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis.
Steere AC; Falk B; Drouin EE; Baxter-Lowe LA; Hammer J; Nepom GT
Arthritis Rheum; 2003 Feb; 48(2):534-40. PubMed ID: 12571864
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.
Drouin EE; Glickstein LJ; Steere AC
J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399
[TBL] [Abstract][Full Text] [Related]
5. Development of autoimmunity in Lyme arthritis.
Guerau-de-Arellano M; Huber BT
Curr Opin Rheumatol; 2002 Jul; 14(4):388-93. PubMed ID: 12118172
[TBL] [Abstract][Full Text] [Related]
6. An ospA frame shift, identified from DNA in Lyme arthritis synovial fluid, results in an outer surface protein A that does not bind protective antibodies.
Fikrig E; Liu B; Fu LL; Das S; Smallwood JI; Flavell RA; Persing DH; Schoen RT; Barthold SW; Malawista SE
J Immunol; 1995 Dec; 155(12):5700-4. PubMed ID: 7499856
[TBL] [Abstract][Full Text] [Related]
7. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
[TBL] [Abstract][Full Text] [Related]
8. Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity?
Bolz DD; Weis JJ
Autoimmunity; 2004 Aug; 37(5):387-92. PubMed ID: 15621562
[TBL] [Abstract][Full Text] [Related]
9. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.
Gross DM; Forsthuber T; Tary-Lehmann M; Etling C; Ito K; Nagy ZA; Field JA; Steere AC; Huber BT
Science; 1998 Jul; 281(5377):703-6. PubMed ID: 9685265
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular aspects of Lyme arthritis.
Gross DM; Huber BT
Cell Mol Life Sci; 2000 Oct; 57(11):1562-9. PubMed ID: 11092451
[TBL] [Abstract][Full Text] [Related]
11. Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells.
Trollmo C; Meyer AL; Steere AC; Hafler DA; Huber BT
J Immunol; 2001 Apr; 166(8):5286-91. PubMed ID: 11290815
[TBL] [Abstract][Full Text] [Related]
12. [Immunopathology of Lyme arthritis].
Pancewicz SA; Rutkowski R; Rutkowski K; Zajkowska JM; Kondrusik M
Pol Merkur Lekarski; 2007 Aug; 23(134):141-4. PubMed ID: 18044347
[TBL] [Abstract][Full Text] [Related]
13. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.
Kalish RA; Leong JM; Steere AC
Infect Immun; 1993 Jul; 61(7):2774-9. PubMed ID: 7685738
[TBL] [Abstract][Full Text] [Related]
14. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
16. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis.
Busch DH; Jassoy C; Brinckmann U; Girschick H; Huppertz HI
J Immunol; 1996 Oct; 157(8):3534-41. PubMed ID: 8871653
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.
Iliopoulou BP; Guerau-de-Arellano M; Huber BT
Arthritis Rheum; 2009 Dec; 60(12):3831-40. PubMed ID: 19950279
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.
Steere AC; Klitz W; Drouin EE; Falk BA; Kwok WW; Nepom GT; Baxter-Lowe LA
J Exp Med; 2006 Apr; 203(4):961-71. PubMed ID: 16585267
[TBL] [Abstract][Full Text] [Related]
19. NMR identification of epitopes of Lyme disease antigen OspA to monoclonal antibodies.
Huang X; Yang X; Luft BJ; Koide S
J Mol Biol; 1998 Aug; 281(1):61-7. PubMed ID: 9680475
[TBL] [Abstract][Full Text] [Related]
20. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis.
Lengl-Janssen B; Strauss AF; Steere AC; Kamradt T
J Exp Med; 1994 Dec; 180(6):2069-78. PubMed ID: 7964484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
